The prostacyclin analogue Iloprost as an early predictor of successful revascularization in diabetic patients affected by critical limb ischemia and foot ulcers

Cardiovasc Revasc Med. 2019 Jul;20(7):621-622. doi: 10.1016/j.carrev.2019.05.009. Epub 2019 May 16.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus*
  • Epoprostenol
  • Foot Ulcer*
  • Humans
  • Iloprost
  • Ischemia / surgery
  • Limb Salvage

Substances

  • Epoprostenol
  • Iloprost